Nativis

About Nativis

EMulate Therapeutics, formerly known as Nativis, is a pioneering company in the medical technology sector, specializing in the development of therapeutic devices that utilize low-level, non-thermal electromagnetic fields to treat cancer and other serious diseases. The company's core product, the Voyager system, is designed to target and disrupt the growth of cancer cells, offering a non-invasive treatment option for patients with recurrent glioblastoma and other challenging conditions. EMulate Therapeutics operates primarily in the healthcare and medical device markets, serving patients, healthcare providers, and research institutions. The business model is centered around the development, clinical testing, regulatory approval, and commercialization of its innovative therapeutic systems. Revenue is generated through product sales, licensing agreements, and strategic partnerships. The company has achieved significant milestones, including FDA acceptance for its Humanitarian Device Exemption application and a distribution agreement for the Indian market.